Is Abeona Therapeutics Inc (ABEO) undervalued? · rev $3.5M
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
This page asks whether Abeona Therapeutics Inc (ABEO) looks cheap on cached numbers — not a DCF toy and not a buy alert.
Latest reported ABEO revenue for 2023-12-31 was $3.5M. Net income was -$54.2M. Revenue was up 147.5% from 2022-12-31 to 2023-12-31. ABEO currently screens at market cap $301.8M.
ABEO currently screens at market cap $301.8M. Cheap versus history or peers still needs a filing reason; a low multiple can be a value trap.
A new ABEO 10-Q can flip this screen overnight. The SEC page is the source.
Not investment advice. Compare ABEO to the stock page model before you treat a low multiple as a gift.
Not investment advice.